What Nanostream does

Nanostream is a privately held company founded in 1999 that, per its firmographic profile, provides products and services to pharmaceutical and biotechnology customers. The firmographic record lists Pasadena, United States as its location and nanostream.com as its corporate web property. In its active period, Nanostream attracted institutional venture capital: a 2001 round led by AGTC and Techno Venture Management with Shamrock Capital Advisors, and a 2003 Series financing of $22,000,000 led by AEA Investors and Lilly Ventures, with Flagship Pioneering and Techno Venture Management also participating. These backers suggest an early-stage life-sciences instrumentation or services thesis at founding.

No information is available in the supplied data regarding Nanostream's specific product portfolio, underlying technology, pricing model, go-to-market motion, revenue mechanics, customer segments, management team, headcount, certifications, patents, or active partnerships beyond a domain-broker arrangement with Spaceship.com. The company has no documented office footprint beyond a Phoenix address traceable to Spaceship.com rather than Nanostream itself.

Operationally, the company appears inactive. The nanostream.com domain is currently listed for sale on Spaceship.com, and the website is a parking page offering domain purchase rather than a functioning corporate presence. No funding rounds, product launches, or strategic moves have been recorded since 2003. The combination of a 20+ year gap in capital activity and an abandoned corporate web property strongly indicates that the business is no longer operating in any material commercial capacity.

Name

Nanostream

Website

https://nanostream.com

Company type

Private

Founded year

1999

Short description

Nanostream was a privately held provider of products and services to pharmaceutical and biotechnology companies, founded in 1999. The company raised venture capital in 2001 and 2003, but its corporate domain is now listed for sale and no active operations are documented.

Ownership category

akta.pro rank

Product category

Biotechnology / Pharmaceutical Products & Services

NAICS

Research and Development in Nanotechnology (541713), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Wholesale-Electronic Parts & Equipment, Nec (5065)

akta.pro primary industry

Crystallization, Particle Engineering & Micronization Services (HLAGAHAJ)

Keywords

• Pharmaceutical products
• Biotech services
• Laboratory instruments
• Drug discovery tools
• Life science products

Headquarters

HQ city

Pasadena

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations

Core offering

Nanostream provides products and services for pharmaceutical and biotechnology companies. The specific product or service categories, technical capabilities, and customer-facing offerings are not detailed in the available source material beyond this general description.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Spaceship.comminorOthersSpaceship.com serves as the domain broker and platform for the sale of the nanostream.com domain. The partnership involves Spaceship facilitating the domain transaction with secure payment processing and transaction support services.

Recent moves4 records

Expansion highlights2 records

Direct peers

• Standard BioTools (formerly Fluidigm): Standard BioTools builds microfluidic and mass cytometry systems for life-sciences research and pharma/biotech applications — historically the closest direct peer to Nanostream's microfluidic/nanoscale systems for pharma.
• 908 Devices: 908 Devices produces microfluidic mass spectrometry and chemical analysis tools used in biopharma and life-sciences R&D and bioprocessing — a direct competitor in microfluidic instrumentation for pharma/biotech.
• Labcyte (now Beckman Coulter Life Sciences): Labcyte built acoustic droplet ejection instrumentation for pharmaceutical and biotech workflows (now part of Beckman Coulter Life Sciences) — a direct peer in precision liquid-handling tools for pharma/biotech.

Broad incumbents

• Bio-Rad Laboratories: Bio-Rad supplies life-science research and clinical diagnostics products, including droplet-based and digital PCR systems, to pharmaceutical and biotech customers — overlapping tools, channels, and customer base.
• Thermo Fisher Scientific: Thermo Fisher is the largest life-sciences tools and pharma services company, supplying instruments, consumables, and services used by the same pharmaceutical and biotech customers Nanostream targeted.
• Bruker Corporation: Bruker provides scientific instruments and analytical solutions for pharma/biotech and life-sciences research, including mass spectrometry and biopharma characterization tools — a broad incumbent peer.
• Agilent Technologies: Agilent provides a broad portfolio of analytical instruments, consumables, and services for pharmaceutical and biotech R&D and quality control — a broad incumbent serving the same end customers as Nanostream.
• Waters Corporation: Waters makes analytical instruments (LC, MS) and consumables widely used in pharmaceutical and biotech R&D and manufacturing — comparable in the life-sciences analytical tools space Nanostream occupied.
• Caliper Life Sciences (now part of Revvity / PerkinElmer): Caliper pioneered lab-on-a-chip and microfluidic systems for drug discovery and life-sciences research and was acquired by PerkinElmer (now Revvity); closely comparable in microfluidic tools for pharma/biotech.
• PerkinElmer / Revvity: Revvity (formerly PerkinElmer) provides life-sciences instrumentation, reagents, and software for pharma/biotech R&D and diagnostics, and acquired Caliper — a broad incumbent comparable to Nanostream in life-sciences tools for pharma.

Market position

Strengths2 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights3 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanostream